US Stock MarketDetailed Quotes

KIDS OrthoPediatrics

Watchlist
  • 21.760
  • +0.990+4.77%
Close Apr 24 16:00 ET
  • 21.760
  • 0.0000.00%
Post 16:05 ET
540.33MMarket Cap-13.27P/E (TTM)

OrthoPediatrics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
37.65%204.73M
40.02%52.67M
36.53%54.57M
33.48%52.8M
41.46%44.69M
21.62%148.73M
21.36%37.61M
14.37%39.97M
20.14%39.56M
34.89%31.59M
Operating revenue
37.65%204.73M
40.02%52.67M
36.53%54.57M
33.48%52.8M
41.46%44.69M
21.62%148.73M
21.36%37.61M
14.37%39.97M
20.14%39.56M
34.89%31.59M
Cost of revenue
49.76%56.13M
56.91%17.1M
60.92%14.51M
25.90%12M
55.86%12.51M
18.50%37.48M
11.56%10.9M
-0.46%9.02M
19.97%9.53M
65.47%8.03M
Gross profit
33.57%148.6M
33.13%35.57M
29.42%40.06M
35.88%40.8M
36.56%32.17M
22.71%111.25M
25.87%26.71M
19.56%30.95M
20.19%30.03M
26.90%23.56M
Operating expense
30.00%178.12M
26.89%44.13M
32.34%45.63M
30.48%46.47M
30.31%41.9M
21.85%137.02M
17.77%34.78M
17.90%34.48M
23.98%35.61M
28.86%32.15M
Selling and administrative expenses
32.48%167.09M
29.37%41.22M
34.89%43.05M
34.54%43.92M
30.95%38.9M
21.28%126.12M
17.73%31.86M
18.05%31.92M
21.01%32.65M
29.58%29.71M
-Selling and marketing expense
21.72%64.3M
31.13%16.78M
20.14%16.75M
22.61%16.59M
12.91%14.17M
14.60%52.82M
6.79%12.8M
16.97%13.94M
8.86%13.53M
28.60%12.55M
-General and administrative expense
40.23%102.79M
28.19%24.43M
46.33%26.3M
42.99%27.33M
44.14%24.73M
26.59%73.3M
26.42%19.06M
18.90%17.97M
31.39%19.11M
30.30%17.16M
Research and development costs
1.28%11.03M
-0.21%2.92M
0.62%2.58M
-14.26%2.54M
22.57%3M
28.90%10.9M
18.20%2.92M
16.09%2.56M
69.78%2.97M
20.67%2.45M
Operating profit
-14.57%-29.52M
-6.20%-8.57M
-57.99%-5.57M
-1.43%-5.67M
-13.18%-9.72M
-18.25%-25.77M
2.92%-8.07M
-5.10%-3.52M
-49.24%-5.59M
-34.53%-8.59M
Net non-operating interest income expense
-1,423.74%-2.62M
-535.31%-1.32M
-1,823.81%-404K
11.22%-261K
-403.33%-637K
108.17%198K
396.72%303K
97.03%-21K
75.74%-294K
137.10%210K
Non-operating interest expense
----
----
1,823.81%404K
-11.22%261K
----
----
----
-97.03%21K
-75.74%294K
----
Total other finance cost
1,423.74%2.62M
----
----
----
403.33%637K
-108.17%-198K
----
----
----
-137.10%-210K
Other net income (expense)
-329.96%-9.79M
-858.60%-6.52M
-1,499.49%-3.17M
-104.63%-120K
-97.60%24K
-79.26%4.26M
144.32%860K
-101.07%-198K
-38.01%2.59M
140.61%1M
Special income (charges)
-537.04%-8.72M
-91,583.33%-5.49M
-227.92%-3.23M
--0
--0
-91.06%2M
-98.75%6K
-105.08%-985K
-54.01%2.3M
126.07%670K
-Less：Restructuring and merger&acquisition
222.58%3.65M
60,983.33%3.65M
--0
--0
--0
88.51%-2.98M
98.75%-6K
--0
54.01%-2.3M
-126.07%-670K
-Less:Impairment of capital assets
86.40%1.84M
--1.84M
--0
----
----
-72.71%985K
--0
-72.71%985K
----
----
-Less:Other special charges
--3.23M
--0
--3.23M
----
----
----
----
----
----
----
Other non- operating income (expenses)
-147.24%-1.07M
-221.19%-1.04M
-91.99%63K
-141.52%-120K
-92.75%24K
225.89%2.26M
767.19%854K
183.28%787K
134.95%289K
215.24%331K
Income before tax
-96.74%-41.93M
-137.71%-16.41M
-144.17%-9.14M
-83.97%-6.05M
-40.05%-10.34M
-477.72%-21.31M
12.58%-6.9M
-125.99%-3.74M
-325.78%-3.29M
21.63%-7.38M
Income tax
-1,115.09%-4.11M
-60.38%-340K
-243.46%-1.22M
95.51%-18K
-340.94%-2.53M
93.17%-338K
-341.67%-212K
120.49%849K
8.66%-401K
-81.07%-574K
Net income
-80.33%-37.82M
-140.16%-16.07M
-72.49%-7.92M
-108.91%-6.03M
-14.68%-7.81M
-1,767.25%-20.97M
14.74%-6.69M
-124.76%-4.59M
-766.67%-2.89M
25.21%-6.81M
Net income continuous Operations
-80.33%-37.82M
-140.16%-16.07M
-72.49%-7.92M
-108.91%-6.03M
-14.68%-7.81M
-1,767.25%-20.97M
14.74%-6.69M
-124.76%-4.59M
-766.67%-2.89M
25.21%-6.81M
Minority interest income
Net income attributable to the parent company
-80.33%-37.82M
-140.16%-16.07M
-72.49%-7.92M
-108.91%-6.03M
-14.68%-7.81M
-1,767.25%-20.97M
14.74%-6.69M
-124.76%-4.59M
-766.67%-2.89M
25.21%-6.81M
Preferred stock dividends
Other preferred stock dividends
0
0
Net income attributable to common stockholders
-80.33%-37.82M
-140.16%-16.07M
-72.49%-7.92M
-108.91%-6.03M
-14.68%-7.81M
-1,798.30%-20.97M
13.07%-6.69M
-125.24%-4.59M
-766.67%-2.89M
25.21%-6.81M
Basic earnings per share
-78.26%-1.64
-137.93%-0.69
-70.00%-0.34
-100.00%-0.26
-13.33%-0.34
-1,633.33%-0.92
17.14%-0.29
-122.73%-0.2
-550.00%-0.13
36.17%-0.3
Diluted earnings per share
-78.26%-1.64
-137.93%-0.69
-70.00%-0.34
-100.00%-0.26
-13.33%-0.34
-1,633.33%-0.92
17.14%-0.29
-122.99%-0.2
-550.00%-0.13
36.17%-0.3
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 37.65%204.73M40.02%52.67M36.53%54.57M33.48%52.8M41.46%44.69M21.62%148.73M21.36%37.61M14.37%39.97M20.14%39.56M34.89%31.59M
Operating revenue 37.65%204.73M40.02%52.67M36.53%54.57M33.48%52.8M41.46%44.69M21.62%148.73M21.36%37.61M14.37%39.97M20.14%39.56M34.89%31.59M
Cost of revenue 49.76%56.13M56.91%17.1M60.92%14.51M25.90%12M55.86%12.51M18.50%37.48M11.56%10.9M-0.46%9.02M19.97%9.53M65.47%8.03M
Gross profit 33.57%148.6M33.13%35.57M29.42%40.06M35.88%40.8M36.56%32.17M22.71%111.25M25.87%26.71M19.56%30.95M20.19%30.03M26.90%23.56M
Operating expense 30.00%178.12M26.89%44.13M32.34%45.63M30.48%46.47M30.31%41.9M21.85%137.02M17.77%34.78M17.90%34.48M23.98%35.61M28.86%32.15M
Selling and administrative expenses 32.48%167.09M29.37%41.22M34.89%43.05M34.54%43.92M30.95%38.9M21.28%126.12M17.73%31.86M18.05%31.92M21.01%32.65M29.58%29.71M
-Selling and marketing expense 21.72%64.3M31.13%16.78M20.14%16.75M22.61%16.59M12.91%14.17M14.60%52.82M6.79%12.8M16.97%13.94M8.86%13.53M28.60%12.55M
-General and administrative expense 40.23%102.79M28.19%24.43M46.33%26.3M42.99%27.33M44.14%24.73M26.59%73.3M26.42%19.06M18.90%17.97M31.39%19.11M30.30%17.16M
Research and development costs 1.28%11.03M-0.21%2.92M0.62%2.58M-14.26%2.54M22.57%3M28.90%10.9M18.20%2.92M16.09%2.56M69.78%2.97M20.67%2.45M
Operating profit -14.57%-29.52M-6.20%-8.57M-57.99%-5.57M-1.43%-5.67M-13.18%-9.72M-18.25%-25.77M2.92%-8.07M-5.10%-3.52M-49.24%-5.59M-34.53%-8.59M
Net non-operating interest income expense -1,423.74%-2.62M-535.31%-1.32M-1,823.81%-404K11.22%-261K-403.33%-637K108.17%198K396.72%303K97.03%-21K75.74%-294K137.10%210K
Non-operating interest expense --------1,823.81%404K-11.22%261K-------------97.03%21K-75.74%294K----
Total other finance cost 1,423.74%2.62M------------403.33%637K-108.17%-198K-------------137.10%-210K
Other net income (expense) -329.96%-9.79M-858.60%-6.52M-1,499.49%-3.17M-104.63%-120K-97.60%24K-79.26%4.26M144.32%860K-101.07%-198K-38.01%2.59M140.61%1M
Special income (charges) -537.04%-8.72M-91,583.33%-5.49M-227.92%-3.23M--0--0-91.06%2M-98.75%6K-105.08%-985K-54.01%2.3M126.07%670K
-Less：Restructuring and merger&acquisition 222.58%3.65M60,983.33%3.65M--0--0--088.51%-2.98M98.75%-6K--054.01%-2.3M-126.07%-670K
-Less:Impairment of capital assets 86.40%1.84M--1.84M--0---------72.71%985K--0-72.71%985K--------
-Less:Other special charges --3.23M--0--3.23M----------------------------
Other non- operating income (expenses) -147.24%-1.07M-221.19%-1.04M-91.99%63K-141.52%-120K-92.75%24K225.89%2.26M767.19%854K183.28%787K134.95%289K215.24%331K
Income before tax -96.74%-41.93M-137.71%-16.41M-144.17%-9.14M-83.97%-6.05M-40.05%-10.34M-477.72%-21.31M12.58%-6.9M-125.99%-3.74M-325.78%-3.29M21.63%-7.38M
Income tax -1,115.09%-4.11M-60.38%-340K-243.46%-1.22M95.51%-18K-340.94%-2.53M93.17%-338K-341.67%-212K120.49%849K8.66%-401K-81.07%-574K
Net income -80.33%-37.82M-140.16%-16.07M-72.49%-7.92M-108.91%-6.03M-14.68%-7.81M-1,767.25%-20.97M14.74%-6.69M-124.76%-4.59M-766.67%-2.89M25.21%-6.81M
Net income continuous Operations -80.33%-37.82M-140.16%-16.07M-72.49%-7.92M-108.91%-6.03M-14.68%-7.81M-1,767.25%-20.97M14.74%-6.69M-124.76%-4.59M-766.67%-2.89M25.21%-6.81M
Minority interest income
Net income attributable to the parent company -80.33%-37.82M-140.16%-16.07M-72.49%-7.92M-108.91%-6.03M-14.68%-7.81M-1,767.25%-20.97M14.74%-6.69M-124.76%-4.59M-766.67%-2.89M25.21%-6.81M
Preferred stock dividends
Other preferred stock dividends 00
Net income attributable to common stockholders -80.33%-37.82M-140.16%-16.07M-72.49%-7.92M-108.91%-6.03M-14.68%-7.81M-1,798.30%-20.97M13.07%-6.69M-125.24%-4.59M-766.67%-2.89M25.21%-6.81M
Basic earnings per share -78.26%-1.64-137.93%-0.69-70.00%-0.34-100.00%-0.26-13.33%-0.34-1,633.33%-0.9217.14%-0.29-122.73%-0.2-550.00%-0.1336.17%-0.3
Diluted earnings per share -78.26%-1.64-137.93%-0.69-70.00%-0.34-100.00%-0.26-13.33%-0.34-1,633.33%-0.9217.14%-0.29-122.99%-0.2-550.00%-0.1336.17%-0.3
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
New Fortress Energy
NFE
5.870
DexCom
DXCM
70.780
Workday
WDAY
236.870
4
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
8.200
5
Teradata Corp
TDC
21.510
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.